Status:
COMPLETED
Use of Expressive Writing in Irritable Bowel Syndrome (IBS)
Lead Sponsor:
Boston University
Collaborating Sponsors:
Takeda Pharmaceuticals North America, Inc.
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to test whether disease-related expressive writing is effective in the treatment of Irritable Bowel Syndrome (IBS).
Detailed Description
Expressive writing involves writing about traumatic, stressful or emotional events. Expressive writing, for as little as 3-5 sessions of 20 minutes, has been found to improve both physical and psychol...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Irritable Bowel syndrome
Exclusion
- Non-English Speakers
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT01192672
Start Date
September 1 2008
End Date
November 1 2010
Last Update
March 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.